• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Jasmine Pennic | HIT Consultant

Particle Health, Hona Integrate to Deliver Longitudinal Data for Informed Clinical Decisions

by Jasmine Pennic 11/07/2023 Leave a Comment

Particle and Hona Partner to Deliver Longitudinal Data for Informed Clinical Decisions

What You Should Know: - Particle Health, an intelligent data platform that aggregates and delivers actionable patient data and insights and Hona have formed a strategic partnership to enhance Hona's AI-driven healthcare solution. Hona is a customizable, HIPAA-compliant artificial intelligence product that searches and converts thousands of health records into one simple patient overview for healthcare providers, - The collaboration between Particle Health and Hona aims to simplify patient
Read More

M&A: Health Catalyst Acquires Cancer Registry Platform ERS

by Jasmine Pennic 11/07/2023 Leave a Comment

M&A: Health Catalyst Acquires Cancer Registry Platform ERS

What You Should Know: - Health Catalyst has acquired Electronic Registry Systems, Inc. (ERS), a prominent cancer registry software and services provider. Financial details of the acquisition were not disclosed. - The acquisition aims to strengthen Health Catalyst's comprehensive data abstraction and registry management capabilities, particularly in conjunction with its ARMUS platform. The addition of ERS enhances Health Catalyst's Tech-Enabled Managed Services (TEMS) offering within the
Read More

Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

by Jasmine Pennic 11/06/2023 Leave a Comment

Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

What You Should Know:  - Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth. - Building on their generative AI collaboration, Accenture and Salesforce will leverage their joint generative AI acceleration hub to develop new solutions and use cases for Salesforce Life Sciences
Read More

Hims & Hers Launches AI Service to Help Providers Personalize Treatments

by Jasmine Pennic 11/06/2023 Leave a Comment

Hims & Hers Launches AI Service to Help Providers Personalize Treatments

What You Should Know:  - Hims & Hers Health, the leading health and wellness platform, has unveiled MedMatch, an AI-powered solution designed to revolutionize healthcare by providing providers with a more intelligent and informed way to deliver personalized care to patients, offering more effective and precise treatments and medications. - The goal of MedMatch is to recommend clinical decisions and treatments informed by the collective knowledge of thousands of providers and
Read More

Survey Shows Burdens on Clinical Research Sites Sharply Increasing Since 2018

by Jasmine Pennic 11/06/2023 Leave a Comment

What You Should Know: - Advarra, a prominent player in regulatory review solutions and clinical research technology, has released findings from its 2023 Study Activation Survey. Since 2018, nearly 60% of sites have experienced an increase in study volume. The survey reveals sites are also managing more sponsor-provided technology, which is now perceived as a higher burden than contracting and budgeting. - The 2023 Study Activation Survey aimed to capture the perspectives and experiences from over 500 North American clinical research professionals. The survey rated the impact of processes such as site feasibility, budgeting and contracting, patient recruitment, and subject compensation on study startup, as well as the role of technology and site tools and their benefits and burdens. Key findings from the survey include: - Technology Utilization: More than half of site respondents utilize various technologies such as electronic data capture (EDC), interactive voice response (IVR), and safety letter distribution systems. Between 33-50% of sites are using electronic patient reported outcomes (ePRO), electronic clinical outcomes assessment (eCOA), learning management, document exchange, and site payment systems in over three-quarters of studies. - Technology Impact: Despite advances in clinical trial systems, sites express concerns about technology's impact on their daily workflows. Sponsor technology setup and training during study startup are considered the most burdensome activities. Over half of sites (55%) find setup and training on sponsor technology extremely or very burdensome, with 67% feeling that it's worse than five years ago. - Multiple Logins: As technology usage increases, site staff face a commensurate increase in the number of logins required, with nearly 70% of respondents reporting having six or more logins per study. - Credential Consolidation: To address the complexity of multiple logins, 81% of respondents believe that using their own site credentials to access various systems would be valuable. - Burden in Clinical Trials: Budgeting (41%) and contracting (36%) are rated as the next extremely or very burdensome activities for clinical trials after sponsor technology setup and training. - Contract and Budget Utilization: Only 36% of sites report that sponsors and contract research organizations (CROs) always or often leverage existing contract terms, and budgets are similarly underutilized, with only 31% stating that sponsors and CROs always or often use existing terms. - Value of eReg Binder Technology: 80% of sites find it extremely or very valuable to have their organization's eReg binder technology connected to the sponsor and CRO technology used for document exchange and review in study startup. - Site Engagement Tools: At least 50% of sites find site engagement tools to be very or extremely useful, with the top four tools, including visit essentials, quick links to other study tools, visit calculator, and protocol text search, rated as very or extremely useful by more than 80% of sites. Feasibility Surveys: Nearly half of sites (49%) say the burden of feasibility surveys has increased over the past five years, possibly due to redundant site capability questions. eConsent: Only 14% of sites report that sponsors or CROs consistently offer eConsent for more than 75% of site studies. Reimbursement Requests: Sites frequently request reimbursement for costs associated with remote monitoring, including CRO monitoring visits (71%) and remote monitoring setup (63%). “Sites are increasingly saddled with complex technologies and duplicative, administrative tasks. We need to come together as an industry and support both sites and sponsors with technology that works for each stakeholder respectively and helps improve clinical research – not hinder it,” said Gadi Saarony, CEO of Advarra. “Advarra uniquely knows and understands the needs of sponsors, CROs, sites, and participants and is committed to driving industrywide stakeholder collaboration and to be the pioneer in connecting the clinical research ecosystem.”

What You Should Know: - Advarra, a prominent player in regulatory review solutions and clinical research technology has released findings from its 2023 Study Activation Survey. Since 2018, nearly 60% of clinical research sites have experienced an increase in study volume. The survey reveals sites are also managing more sponsor-provided technology, which is now perceived as a higher burden than contracting and budgeting. - The 2023 Study Activation Survey aimed to capture the perspectives
Read More

FCC Launches Inquiry into Broadband Connectivity for Maternal Health

by Jasmine Pennic 11/06/2023 Leave a Comment

FCC Launches Inquiry into Broadband Connectivity for Maternal Health

What You Should Know: - The Federal Communications Commission (FCC) has voted to initiate an inquiry aimed at expanding and improving the Mapping Broadband Health in America platform to enhance the use of digital health tools for better maternal care. - The United States faces rising maternal mortality and severe maternal morbidity rates, and research indicates that many of these issues are preventable. Access to broadband internet and its connection to healthcare services can help address
Read More

SubjectWell Acquires PatientCentra, Expanding Ability to Recruit for Rare Disease/Oncology Indications

by Jasmine Pennic 11/03/2023 Leave a Comment

SubjectWell Acquires PatientCentra, Expanding Ability to Recruit for Rare Disease/Oncology Indications

What You Should Know:  - SubjectWell, a patient access marketplace connecting individuals with chronic health conditions to healthcare options, has acquired PatientCentra, a company specializing in global patient recruitment and personalized recruitment journeys. Financial details of the acquisition were not disclosed.  - This strategic acquisition enhances SubjectWell's capacity to serve patient recruitment needs for international clinical studies and further extends its
Read More

Labor Remains Top Challenges for Hospitals/Health System Exec, Report Finds

by Jasmine Pennic 11/03/2023 Leave a Comment

Labor Remains Top Challenges for Hospitals/Health System Exec, Report Finds

What You Should Know:  - Hospitals’ financial performance declined slightly in September compared to the previous month, according to the latest National Hospital Flash Report from Kaufman Hall. Across the board, there was a decrease in patient volume during this period compared to 2022.  - The latest Physician Flash Report reveals the need for organizations to be more strategic about how they utilize and retain providers and support staff.  Physicians are operating at
Read More

Covera Health Secures Up to $50M to Revolutionize Radiology Nationwide

by Jasmine Pennic 11/02/2023 Leave a Comment

Covera Health Secures Up to $50M to Revolutionize Radiology Nationwide

What You Should Know:  - Covera Health, an AI-enabled diagnostic technology company, has announced securing up to $50M in additional Series C funding. This substantial funding aims to support their mission of reshaping the role of radiology on a national scale. - The company's platform employs advanced data analytics and AI to enhance the quality and efficiency of radiology services. Their innovative approach focuses on improving radiology outcomes while reducing costs and unnecessary
Read More

Amidst AI Promise, Health Information Workforce Shortages Persist: AHIMA Survey Revels

by Jasmine Pennic 11/02/2023 Leave a Comment

Amidst AI Promise, Health Information Workforce Shortages Persist: AHIMA Survey Revels

What You Should Know: - A new survey conducted by AHIMA reveals that 66% of health information (HI) professionals have experienced ongoing staffing shortages in their workplaces over the past two years. These shortages were notably prevalent in areas such as data quality, consumer health information, revenue cycle management, privacy, risk, and compliance, and data analytics. - The report, “Health Information Workforce: Survey Results on Workforce Challenges and the Role of Emerging
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 68
  • Go to page 69
  • Go to page 70
  • Go to page 71
  • Go to page 72
  • Interim pages omitted …
  • Go to page 415
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |